<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1199" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1199/" /><meta name="ncbi_pagename" content="Frontotemporal Dementia, Chromosome 3-Linked - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Frontotemporal Dementia, Chromosome 3-Linked - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Frontotemporal Dementia, Chromosome 3-Linked" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2012/10/04" /><meta name="citation_author" content="Ida E Holm" /><meta name="citation_author" content="Jørgen E Nielsen" /><meta name="citation_author" content="Jeremy M Brown" /><meta name="citation_author" content="Peter Johannsen" /><meta name="citation_author" content="Adrian M Isaacs" /><meta name="citation_pmid" content="20301378" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1199/" /><meta name="citation_keywords" content="FTD-3" /><meta name="citation_keywords" content="FTD-3" /><meta name="citation_keywords" content="Charged multivesicular body protein 2b" /><meta name="citation_keywords" content="CHMP2B" /><meta name="citation_keywords" content="Frontotemporal Dementia, Chromosome 3-Linked" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Frontotemporal Dementia, Chromosome 3-Linked" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Ida E Holm" /><meta name="DC.Contributor" content="Jørgen E Nielsen" /><meta name="DC.Contributor" content="Jeremy M Brown" /><meta name="DC.Contributor" content="Peter Johannsen" /><meta name="DC.Contributor" content="Adrian M Isaacs" /><meta name="DC.Date" content="2012/10/04" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1199/" /><meta name="description" content="Chromosome 3-linked frontotemporal dementia (FTD3) has been described in a single family from Denmark and in one individual with familial FTD3 from Belgium. It typically starts between ages 46 and 65 years with subtle personality changes and slowly progressive behavioral changes, dyscalculia, and language disturbances. Disinhibition or loss of initiative is the most common presenting symptom. The disease progresses over a few years into profound dementia with mutism. Several individuals have developed an asymmetric akinetic rigid syndrome with arm and gait dystonia and pyramidal signs that may be related to treatment with neuroleptic drugs. Disease duration may be as short as three years or longer than 20 years." /><meta name="og:title" content="Frontotemporal Dementia, Chromosome 3-Linked" /><meta name="og:type" content="book" /><meta name="og:description" content="Chromosome 3-linked frontotemporal dementia (FTD3) has been described in a single family from Denmark and in one individual with familial FTD3 from Belgium. It typically starts between ages 46 and 65 years with subtle personality changes and slowly progressive behavioral changes, dyscalculia, and language disturbances. Disinhibition or loss of initiative is the most common presenting symptom. The disease progresses over a few years into profound dementia with mutism. Several individuals have developed an asymmetric akinetic rigid syndrome with arm and gait dystonia and pyramidal signs that may be related to treatment with neuroleptic drugs. Disease duration may be as short as three years or longer than 20 years." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1199/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/ftd-chmp2b/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1199/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8C7D22DFC876510000000005020254.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1199_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1199_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/friedreich/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/fructose1-6-def/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1199_"><span class="title" itemprop="name">Frontotemporal Dementia, Chromosome 3-Linked</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonym: FTD-3</div><p class="contrib-group"><span itemprop="author">Ida E Holm</span>, MD, DMSc, <span itemprop="author">J&#x000f8;rgen E Nielsen</span>, MD, PhD, <span itemprop="author">Jeremy M Brown</span>, MD, <span itemprop="author">Peter Johannsen</span>, MD, PhD, and <span itemprop="author">Adrian M Isaacs</span>, DPhil.</p><a data-jig="ncbitoggler" href="#__NBK1199_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1199_ai__"><div class="contrib half_rhythm"><span itemprop="author">Ida E Holm</span>, MD, DMSc<div class="affiliation small">Laboratory for Experimental Neuropathology<br />Department of Pathology<br />Randers Hospital<br />Randers, Denmark</div><div class="affiliation small">Institute of Clinical Medicine<br />Aarhus University<br />Aarhus, Denmark</div></div><div class="contrib half_rhythm"><span itemprop="author">J&#x000f8;rgen E Nielsen</span>, MD, PhD<div class="affiliation small">Neurogenetics Clinic<br />Memory Disorders Research Group<br />Rigshospitalet<br />Copenhagen, Denmark</div></div><div class="contrib half_rhythm"><span itemprop="author">Jeremy M Brown</span>, MD<div class="affiliation small">Department of Neurology<br />Addenbrooke's Hospital<br />Cambridge, United Kingdom</div></div><div class="contrib half_rhythm"><span itemprop="author">Peter Johannsen</span>, MD, PhD<div class="affiliation small">Memory Disorders Research Group<br />Rigshospitalet<br />Copenhagen, Denmark</div></div><div class="contrib half_rhythm"><span itemprop="author">Adrian M Isaacs</span>, DPhil<div class="affiliation small">Department of Neurodegenerative Disease<br />Institute of Neurology<br />University College London<br />London, United Kingdom</div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">August 23, 2007</span>; Last Update: <span itemprop="dateModified">October 4, 2012</span>.</p><p><em>Estimated reading time: 16 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="ftd-chmp2b.Summary" itemprop="description"><h2 id="_ftd-chmp2b_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Chromosome 3-linked frontotemporal dementia (FTD3) has been described in a single family from Denmark and in one individual with <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> FTD3 from Belgium. It typically starts between ages 46 and 65 years with subtle personality changes and slowly progressive behavioral changes, dyscalculia, and language disturbances. Disinhibition or loss of initiative is the most common presenting symptom. The disease progresses over a few years into profound dementia with mutism. Several individuals have developed an asymmetric akinetic rigid syndrome with arm and gait dystonia and pyramidal signs that may be related to treatment with neuroleptic drugs. Disease duration may be as short as three years or longer than 20 years.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of FTD3 is supported by the clinical findings of behavioral-variant frontotemporal dementia with a positive family history consistent with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> inheritance. Generalized cortical and central atrophy may be seen on structural neuroimaging. Neuropathology shows ubiquitin-positive, TDP-43-negative and FUS-negative cytoplasmic intraneuronal inclusions in the hippocampal dentate granule cells and in neurons in the frontal and temporal cortex. <i>CHMP2B</i> is the only <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> in which pathogenic variants are known to cause FTD3. The definitive diagnosis of FTD3 relies on demonstration of a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>CHMP2B</i>.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Caregivers need information and psychological support to manage the behavioral changes and the loss of insight and judgment in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>FTD3 is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. The <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> is considered to be complete; most individuals with FTD3 have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent. To date, no cases resulting from <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variants have been identified. Each child of an individual with FTD3 has a 50% chance of inheriting the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. If the pathogenic variant has been identified in the family, prenatal testing is possible through laboratories offering either testing for the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> of interest or <a class="def" href="/books/n/gene/glossary/def-item/custom-testing/">custom testing</a>.</p></div></div><div id="ftd-chmp2b.Diagnosis"><h2 id="_ftd-chmp2b_Diagnosis_">Diagnosis</h2><div id="ftd-chmp2b.Clinical_Diagnosis"><h3>Clinical Diagnosis</h3><p>The diagnosis of <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 3-linked frontotemporal dementia (FTD3) is supported by the following findings:</p><ul><li class="half_rhythm"><div>Frontotemporal dementia</div></li><li class="half_rhythm"><div>Generalized atrophy on neuroimaging:</div><ul><li class="half_rhythm"><div>Computed tomography (CT) or magnetic resonance imaging (MRI) show generalized cortical and central atrophy and ventricular enlargement [<a class="bk_pop" href="#ftd-chmp2b.REF.gydesen.2002.1585">Gydesen et al 2002</a>].</div></li><li class="half_rhythm"><div>PET-CBF scanning shows a global reduction in cortical cerebral blood flow with sparing of the visual cortex and basal ganglia [<a class="bk_pop" href="#ftd-chmp2b.REF.gydesen.2002.1585">Gydesen et al 2002</a>].</div></li></ul></li><li class="half_rhythm"><div>Family history of frontotemporal dementia in two or more first-degree relatives consistent with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a></div></li><li class="half_rhythm"><div>Neuropathology showing ubiquitin-positive, TDP-43-negative, and FUS-negative cytoplasmic intraneuronal inclusions in the hippocampal dentate granule cells and in neurons in the frontal and temporal cortex [<a class="bk_pop" href="#ftd-chmp2b.REF.holm.2007.884">Holm et al 2007</a>, <a class="bk_pop" href="#ftd-chmp2b.REF.holm.2009.719">Holm et al 2009</a>]</div></li></ul><p>The definitive diagnosis of FTD3 relies on demonstration of a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>CHMP2B</i> [<a class="bk_pop" href="#ftd-chmp2b.REF.skibinski.2005.806">Skibinski et al 2005</a>, <a class="bk_pop" href="#ftd-chmp2b.REF.lindquist.2008.667">Lindquist et al 2008</a>].</p></div><div id="ftd-chmp2b.Molecular_Genetic_Testing"><h3>Molecular Genetic Testing</h3><p><b>Gene.</b>
<i>CHMP2B</i> is the only <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> in which pathogenic variants are known to cause FTD3.</p><div id="ftd-chmp2b.T.molecular_genetic_testing_u" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Frontotemporal Dementia, Chromosome 3-Linked</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1199/table/ftd-chmp2b.T.molecular_genetic_testing_u/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ftd-chmp2b.T.molecular_genetic_testing_u_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_ftd-chmp2b.T.molecular_genetic_testing_u_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_ftd-chmp2b.T.molecular_genetic_testing_u_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Test Method</th><th id="hd_h_ftd-chmp2b.T.molecular_genetic_testing_u_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Variants Detected&#x000a0;<sup>2</sup></th><th id="hd_h_ftd-chmp2b.T.molecular_genetic_testing_u_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Variant Detection Frequency by Test Method&#x000a0;<sup>3</sup></th></tr></thead><tbody><tr><td headers="hd_h_ftd-chmp2b.T.molecular_genetic_testing_u_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>CHMP2B</i></td><td headers="hd_h_ftd-chmp2b.T.molecular_genetic_testing_u_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>4</sup></td><td headers="hd_h_ftd-chmp2b.T.molecular_genetic_testing_u_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence variants, including <a class="figpopup" href="/books/NBK1199/table/ftd-chmp2b.T.selected_chmp2b_pathogenic/?report=objectonly" target="object" rid-figpopup="figftdchmp2bTselectedchmp2bpathogenic" rid-ob="figobftdchmp2bTselectedchmp2bpathogenic">c.532-1G&#x0003e;C</a>&#x000a0;<sup>5</sup></td><td headers="hd_h_ftd-chmp2b.T.molecular_genetic_testing_u_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>6</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="ftd-chmp2b.TF.1.1"><p class="no_margin">See <a href="/books/NBK1199/#ftd-chmp2b.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="ftd-chmp2b.TF.1.2"><p class="no_margin">See <a href="#ftd-chmp2b.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants.</p></div></dd><dt>3. </dt><dd><div id="ftd-chmp2b.TF.1.3"><p class="no_margin">The ability of the test method used to detect a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> that is present in the indicated <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a></p></div></dd><dt>4. </dt><dd><div id="ftd-chmp2b.TF.1.4"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>5. </dt><dd><div id="ftd-chmp2b.TF.1.5"><p class="no_margin">The c.532-1G&#x0003e;C <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>CHMP2B</i>, a change in the acceptor site of <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 6, has only been identified in one large Danish kindred with frontotemporal dementia [<a class="bk_pop" href="#ftd-chmp2b.REF.gydesen.2002.1585">Gydesen et al 2002</a>, <a class="bk_pop" href="#ftd-chmp2b.REF.skibinski.2005.806">Skibinski et al 2005</a>, <a class="bk_pop" href="#ftd-chmp2b.REF.lindquist.2008.667">Lindquist et al 2008</a>].</p></div></dd><dt>6. </dt><dd><div id="ftd-chmp2b.TF.1.6"><p class="no_margin">A number of other <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases (i.e., a single occurrence in a family) and <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> cases of FTD have been screened for pathogenic variants in <i>CHMP2B</i> [<a class="bk_pop" href="#ftd-chmp2b.REF.cannon.2006.83">Cannon et al 2006</a>, <a class="bk_pop" href="#ftd-chmp2b.REF.momeni.2006a.77">Momeni et al 2006a</a>, <a class="bk_pop" href="#ftd-chmp2b.REF.rizzu.2006.944">Rizzu et al 2006</a>, <a class="bk_pop" href="#ftd-chmp2b.REF.ghanim.2010.2032">Ghanim et al 2010</a>]. Individuals with ALS, as well as controls, have likewise been screened for pathogenic variants in <i>CHMP2B</i> [<a class="bk_pop" href="#ftd-chmp2b.REF.parkinson.2006.1074">Parkinson et al 2006</a>, <a class="bk_pop" href="#ftd-chmp2b.REF.blair.2008.849">Blair et al 2008</a>, <a class="bk_pop" href="#ftd-chmp2b.REF.cox.2010.e9872">Cox et al 2010</a>]. These studies have only revealed cases with pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants of currently <a class="def" href="/books/n/gene/glossary/def-item/unknown-significance/">unknown significance</a> [<a class="bk_pop" href="#ftd-chmp2b.REF.isaacs.2011.246">Isaacs et al 2011</a>].</p></div></dd></dl></div></div></div></div><div id="ftd-chmp2b.Testing_Strategy"><h3>Testing Strategy</h3><p><b>To confirm/establish the diagnosis in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The definitive diagnosis of FTD3 relies on demonstration of a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>CHMP2B</i>.</p><p><b>Predictive testing</b> for at-risk asymptomatic adult family members requires prior identification of the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the family.</p><p><b>Prenatal diagnosis and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> (PGD)</b> for at-risk pregnancies require prior identification of the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the family.</p></div></div><div id="ftd-chmp2b.Clinical_Characteristics"><h2 id="_ftd-chmp2b_Clinical_Characteristics_">Clinical Characteristics</h2><div id="ftd-chmp2b.Clinical_Description"><h3>Clinical Description</h3><p>Chromosome 3-linked frontotemporal dementia (FTD3) is an early onset dementia affecting primarily frontal functions. The disease typically starts with subtle personality changes and slowly progressive behavioral changes, dyscalculia, and language disturbances. The disease has so far been described in a family which originates and resides in western Jutland, Denmark as well as in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual with <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> FTD3 from Belgium. The first description of this family was by <a class="bk_pop" href="#ftd-chmp2b.REF.gydesen.1987.276">Gydesen et al [1987]</a>.</p><p>Symptoms usually start between ages 46 and 65 years, with an average age of onset of 57 years. Disease duration is from three to more than 20 years. The disease progresses over a few years into profound dementia with mutism [<a class="bk_pop" href="#ftd-chmp2b.REF.gydesen.2002.1585">Gydesen et al 2002</a>, <a class="bk_pop" href="#ftd-chmp2b.REF.brown.2004.274">Brown et al 2004</a>].</p><p><b>Behavioral changes.</b> Disinhibition or loss of initiative is the most common presenting symptom. Affected individuals lose interest in their environment and neglect personal hygiene. The manifestations may vary from very disinhibited to very apathetic. Affected individuals may show inappropriate emotional responses. Hyperorality is common including overeating sweet foods and chain smoking. Restlessness, disinhibition, and lack of insight into their illness are common features. Stereotyped behavioral routines are frequent [<a class="bk_pop" href="#ftd-chmp2b.REF.gydesen.2002.1585">Gydesen et al 2002</a>, <a class="bk_pop" href="#ftd-chmp2b.REF.brown.2004.274">Brown et al 2004</a>].</p><p><b>Psychiatric symptoms.</b> Psychotic symptoms are probably unusual, but it is difficult to determine if a very disinhibited person is psychotic. Some individuals develop depressive symptoms early in the illness; they are typically mild.</p><p><b>Cognitive decline.</b> Dyscalculia can be an early feature. Spontaneous speech declines, although repetition and reading from a text is relatively preserved. Perseveration, repetitive utterances, and echolalia are common. Affected individuals develop a non-fluent aphasia and then often become mute. Route-finding problems or visuospatial problems are unusual. Mini-Mental Status Examination (MMSE) scores are relatively preserved early in the disease, followed by a sharp decline with worsening aphasia [<a class="bk_pop" href="#ftd-chmp2b.REF.gydesen.2002.1585">Gydesen et al 2002</a>, <a class="bk_pop" href="#ftd-chmp2b.REF.brown.2004.274">Brown et al 2004</a>].</p><p><b>Extrapyramidal signs.</b> Four years into the illness, several individuals have developed a striking motor syndrome that develops into an asymmetric akinetic rigid syndrome with arm and gait dystonia and pyramidal signs. This syndrome may be related to treatment with neuroleptic drugs [<a class="bk_pop" href="#ftd-chmp2b.REF.gydesen.2002.1585">Gydesen et al 2002</a>, <a class="bk_pop" href="#ftd-chmp2b.REF.brown.2004.274">Brown et al 2004</a>].</p><p><b>Epilepsy.</b> Generalized tonic-clonic epileptic seizures appear to be uncommon in individuals with FTD3.</p><p><b>Motor neuron disease.</b> Severe motor neuron disease has not been described in individuals with FTD3 but some signs of motor neuron involvement (e.g., fasciculations) can be seen.</p><p><b>Neuropathology.</b> Severe generalized atrophy (predominantly in the frontotemporal region) is seen; brain weight is below 1000 g.</p><p>Microscopic analysis reveals neuronal loss, gliosis, and spongiosis in the superficial cortical layers.</p><p>Immunohistochemical analysis shows pathologic accumulation of ubiquitin-positive, TDP-43-negative and FUS-negative cytoplasmic inclusions in the hippocampal dentate granule cells and in a few cortical neurons [<a class="bk_pop" href="#ftd-chmp2b.REF.holm.2007.884">Holm et al 2007</a>, <a class="bk_pop" href="#ftd-chmp2b.REF.holm.2009.719">Holm et al 2009</a>]. The neuropathology is currently classified as FTLD-UPS [<a class="bk_pop" href="#ftd-chmp2b.REF.mackenzie.2010.1">Mackenzie et al 2010</a>].</p></div><div id="ftd-chmp2b.GenotypePhenotype_Correlation"><h3>Genotype-Phenotype Correlations</h3><p>Three different pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants have been found in three individuals with a lower motor neuron-predominant variant of amyotrophic lateral sclerosis termed primary muscular atrophy (PMA) [<a class="bk_pop" href="#ftd-chmp2b.REF.cox.2010.e9872">Cox et al 2010</a>]. However, the pathogenicity of these changes is presently unclear (see <a href="#ftd-chmp2b.Molecular_Genetics">Molecular Genetics</a> and <a class="bk_pop" href="#ftd-chmp2b.REF.isaacs.2011.246">Isaacs et al [2011]</a> for a further discussion of these missense variants.</p></div><div id="ftd-chmp2b.Penetrance"><h3>Penetrance</h3><p>Penetrance appears to be nearly complete in the Danish family.</p></div><div id="ftd-chmp2b.Anticipation"><h3>Anticipation</h3><p>There is no evidence for <a class="def" href="/books/n/gene/glossary/def-item/anticipation/">anticipation</a> in FTD3.</p></div><div id="ftd-chmp2b.Nomenclature"><h3>Nomenclature</h3><p>FTD3 was originally described as <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> nonspecific dementia. Molecular genetic studies published by <a class="bk_pop" href="#ftd-chmp2b.REF.brown.1995.1625">Brown et al [1995]</a> demonstrated linkage of the disease-associated <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> in the Danish family to the pericentromeric region of <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 3, leading to the designation chromosome 3-linked frontotemporal dementia (FTD3).</p><p>Following identification of a causative <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>CHMP2B</i> [<a class="bk_pop" href="#ftd-chmp2b.REF.skibinski.2005.806">Skibinski et al 2005</a>], FTD3 has sometimes been referred to as <i>CHMP2B</i>-related frontotemporal dementia.</p></div><div id="ftd-chmp2b.Prevalence"><h3>Prevalence</h3><p>FTD3 has only been described in one large Danish kindred [<a class="bk_pop" href="#ftd-chmp2b.REF.gydesen.2002.1585">Gydesen et al 2002</a>, <a class="bk_pop" href="#ftd-chmp2b.REF.skibinski.2005.806">Skibinski et al 2005</a>] and in one <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual with <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> FTD from Belgium [<a class="bk_pop" href="#ftd-chmp2b.REF.van_der_zee.2008.313">van der Zee et al 2008</a>].</p></div></div><div id="ftd-chmp2b.Genetically_Related_Allelic_D"><h2 id="_ftd-chmp2b_Genetically_Related_Allelic_D_">Genetically Related (Allelic) Disorders</h2><p>No other phenotypes are known to be associated with pathogenic variants in <i>CHMP2B</i>.</p></div><div id="ftd-chmp2b.Differential_Diagnosis"><h2 id="_ftd-chmp2b_Differential_Diagnosis_">Differential Diagnosis</h2><p>Pathogenic variants in <i>CHMP2B</i> have only been identified in one large Danish kindred with frontotemporal dementia [<a class="bk_pop" href="#ftd-chmp2b.REF.gydesen.2002.1585">Gydesen et al 2002</a>, <a class="bk_pop" href="#ftd-chmp2b.REF.skibinski.2005.806">Skibinski et al 2005</a>, <a class="bk_pop" href="#ftd-chmp2b.REF.lindquist.2008.667">Lindquist et al 2008</a>], and an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual with <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> FTD3 from Belgium [<a class="bk_pop" href="#ftd-chmp2b.REF.van_der_zee.2008.313">van der Zee et al 2008</a>].</p><p>Pathogenic variants in <i>CHMP2B</i> are considered to be a much rarer cause of frontotemporal dementia than pathogenic variants in <i>MAPT</i> (encoding tau), <i>GRN</i> (encoding progranulin), or <i>C9orf72</i>.</p><ul><li class="half_rhythm"><div><b>Frontotemporal dementia with parkinsonism-17 (FTDP-17).</b> Pathogenic variants in <i>MAPT</i> (encoding tau) are causative. The resulting frontotemporal dementia can be associated with extrapyramidal signs (rigidity, bradykinesia, supranuclear palsy, and saccadic eye movement disorders) [<a class="bk_pop" href="#ftd-chmp2b.REF.foster.1997.706">Foster et al 1997</a>, <a class="bk_pop" href="#ftd-chmp2b.REF.bird.1999.741">Bird et al 1999</a>]. Symptoms usually start between ages 40 and 60 years, but may occur earlier or later. The disease progresses over a few years into profound dementia with mutism. Disease duration is usually between five and ten years but may be up to 20 to 30 years. Inheritance is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>.</div></li><li class="half_rhythm"><div><a href="/books/n/gene/ftd-grn/"><b><i>GRN</i>-related frontotemporal dementia</b></a>
<b>(FTD-<i>GRN</i>)</b> generally affects the frontal and temporal cortex, leading to behavioral changes, executive dysfunction, and language disturbances. In FTD-<i>GRN</i>, the parietal cortex and basal ganglia may be <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> as well, resulting in parkinsonism, cortical basal syndrome, and memory impairment [<a class="bk_pop" href="#ftd-chmp2b.REF.baker.2006.916">Baker et al 2006</a>, <a class="bk_pop" href="#ftd-chmp2b.REF.masellis.2006.3115">Masellis et al 2006</a>, <a class="bk_pop" href="#ftd-chmp2b.REF.mukherjee.2006.314">Mukherjee et al 2006</a>, <a class="bk_pop" href="#ftd-chmp2b.REF.behrens.2007.1">Behrens et al 2007</a>, <a class="bk_pop" href="#ftd-chmp2b.REF.josephs.2007.142">Josephs et al 2007</a>, <a class="bk_pop" href="#ftd-chmp2b.REF.mesulam.2007.43">Mesulam et al 2007</a>, <a class="bk_pop" href="#ftd-chmp2b.REF.spina.2007.820">Spina et al 2007</a>]. The age of onset of FTD-<i>GRN</i> ranges from 48 to 83 years with a mean of 59&#x000b1;7 years. Inheritance is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>.</div></li><li class="half_rhythm"><div><a href="/books/n/gene/ibmpfd/"><b>Inclusion body myopathy associated with Paget disease of bone (PDB) and/or frontotemporal dementia</b></a>
<b>(IBMPFD)</b> is characterized by adult-onset proximal and distal muscle weakness (clinically resembling a limb-girdle muscular dystrophy syndrome), early-onset PDB, and premature frontotemporal dementia (FTD). Muscle weakness progresses to involve other limb and respiratory muscles. Cardiac failure and cardiomyopathy have been observed in later stages. PDB involves focal areas of increased bone turnover that typically lead to spine and/or hip pain and localized enlargement and deformity of the long bones; pathologic fractures occur on occasion. Early stages of FTD are characterized by dysnomia, dyscalculia, comprehension deficits, paraphasic errors, and relative preservation of memory; and later stages by inability to speak, auditory comprehension deficits for even one-step commands, alexia, and agraphia. Mean age at diagnosis for muscle disease and PDB is 42 years; for FTD, 55 years. <i>VCP</i> is the only <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> known to be associated with IBMPFD. Inheritance is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>.</div></li><li class="half_rhythm"><div><a href="/books/n/gene/als-ftd/"><b><i>C9orf72</i>-related frontotemporal dementia</b></a> is characterized by adult-onset rapidly progressive features of frontotemporal dementia, <a href="/books/n/gene/als-overview/">amyotrophic lateral sclerosis</a>, or a combination of both in one individual. This condition demonstrates significant <a class="def" href="/books/n/gene/glossary/def-item/intrafamilial-variability/">intrafamilial variability</a>. It is caused by an expanded hexanucleotide repeat in the noncoding region of the <a class="def" href="/books/n/gene/glossary/def-item/open-reading-frame/">open reading frame</a> 72 <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> on <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 9 [<a class="bk_pop" href="#ftd-chmp2b.REF.dejesushernandez.2011.245">DeJesus-Hernandez et al 2011</a>, <a class="bk_pop" href="#ftd-chmp2b.REF.renton.2011.257">Renton et al 2011</a>].</div></li></ul><p>The above differential diagnoses can be ruled out by neuropathologic examination (as each entity shows distinct characteristics [<a class="bk_pop" href="#ftd-chmp2b.REF.cairns.2007.5">Cairns et al 2007</a>]) or by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</p><p><b>Other considerations.</b> Structural imaging may show a frontal preponderance of the generalized atrophy and may exclude other causes of dementia (e.g., frontal meningeoma, chronic subdural hematoma).</p><ul><li class="half_rhythm"><div>The diagnosis of Alzheimer disease should be considered in individuals with mild behavioral changes, prominent memory disturbance and loss of initiative, or word-finding problems in the absence of evident frontotemporal atrophy on neuroimaging (see <a href="/books/n/gene/alzheimer/">Alzheimer Disease Overview</a>).</div></li><li class="half_rhythm"><div>Other <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> neurologic diseases associated with dementia such as <a href="/books/n/gene/huntington/">Huntington disease</a> and dementia with Lewy bodies also need to be considered.</div></li><li class="half_rhythm"><div>Non-genetic acquired causes of dementia should always be considered.</div></li></ul></div><div id="ftd-chmp2b.Management"><h2 id="_ftd-chmp2b_Management_">Management</h2><div id="ftd-chmp2b.Evaluations_Following_Initial"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease in an individual diagnosed with <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 3-linked frontotemporal dementia (FTD3), the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>A general medical history and family history</div></li><li class="half_rhythm"><div>Physical and neurologic examination</div></li><li class="half_rhythm"><div>Evaluation of the extent and profile of cognitive disturbance by neuropsychological examination</div></li><li class="half_rhythm"><div>Consultation with a genetic counselor</div></li></ul></div><div id="ftd-chmp2b.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>Behavioral changes and the loss of insight and judgment in individuals with FTD3 often present a considerable burden for caregivers. Information about the disease and psychological support for partners or other caregivers is essential.</p><p>The behavioral and psychological symptoms (BPSD) should be treated as in other types of FTD. There is no consensus treatment guideline for FTD3. In clinical practice those <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals who present with very aggressive symptoms have proven quite difficult to treat and have in some cases required high doses of antipsychotics and/or antidepressants in order to relieve the physical aggressiveness.</p></div><div id="ftd-chmp2b.Surveillance"><h3>Surveillance</h3><p>Members of the Danish family with FTD3 are followed in the Copenhagen Memory Disorders Clinic, a multidisciplinary clinic involving neurologic and psychiatric services, <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a>, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>, and clinical diagnostic and follow-up medical service.</p></div><div id="ftd-chmp2b.Evaluation_of_Relatives_at_Ri"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#ftd-chmp2b.Related_Genetic_Counseling_Is">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="ftd-chmp2b.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Experimental studies with <a class="def" href="/books/n/gene/glossary/def-item/gene-therapy/">gene therapy</a> are ongoing [<a class="bk_pop" href="#ftd-chmp2b.REF.nielsen.2012.521">Nielsen et al 2012</a>].</p><p>Search <a href="https://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions.</p></div></div><div id="ftd-chmp2b.Genetic_Counseling"><h2 id="_ftd-chmp2b_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="ftd-chmp2b.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Chromosome 3-linked frontotemporal dementia (FTD3) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p></div><div id="ftd-chmp2b.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Most individuals diagnosed with FTD3 would be expected to have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent.</div></li><li class="half_rhythm"><div>A <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with FTD3 may have the disorder as the result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. To date, no cases resulting from <i>de novo</i> pathogenic variants have been identified.</div></li><li class="half_rhythm"><div>Recommendations for the evaluation of parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> include neurologic examination and/or <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>. Evaluation of parents may determine that one is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> but has escaped previous diagnosis because of a milder phenotypic presentation. Therefore, an apparently negative family history cannot be confirmed until appropriate evaluations have been performed.</div></li></ul><p>Note: Although 100% of individuals diagnosed with FTD3 have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent, the family history may appear to be negative because of failure to recognize the disorder in family members, early death of the parent before the onset of symptoms, or late onset of the disease in the affected parent.</p><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to the sibs of the proband depends on the genetic status of the proband's parents:</p><ul><li class="half_rhythm"><div>If a parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, the risk to the sibs is 50%.</div></li><li class="half_rhythm"><div>When the parents are clinically unaffected, the risk to the sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> appears to be low.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each child of an individual with FTD3 has a 50% chance of inheriting the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p><b>Other family members of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to other family members depends on the status of the proband's parents: if a parent is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, his or her family members may be at risk.</p></div><div id="ftd-chmp2b.Related_Genetic_Counseling_Is"><h3>Related Genetic Counseling Issues</h3><p><b>Considerations in families with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</b> When neither parent of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> condition has clinical evidence of the disorder, it is likely that the proband has a <i>de novo</i> pathogenic variant. However, possible non-medical explanations including <a class="def" href="/books/n/gene/glossary/def-item/alternate-paternity/">alternate paternity</a> or maternity (e.g., with assisted reproduction) or undisclosed adoption could also be explored.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or at risk.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="ftd-chmp2b.Prenatal_Testing_and_Preimpla"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>CHMP2B</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="ftd-chmp2b.Resources"><h2 id="_ftd-chmp2b_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Association for Frontotemporal Degeneration (AFTD)</b></div><div><b>Phone:</b> 866-507-7222 (Toll-free Helpline); 267-514-7221</div><div><b>Email:</b> info@theaftd.org</div><div><a href="http://www.theaftd.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.theaftd.org</a></div></li><li class="half_rhythm"><div><b>National Institute of Neurological Disorders and Stroke (NINDS)</b></div><div>PO Box 5801</div><div>Bethesda MD 20824</div><div><b>Phone:</b> 800-352-9424 (toll-free); 301-496-5751; 301-468-5981 (TTY)</div><div><a href="https://www.ninds.nih.gov/Disorders/All-Disorders/Frontotemporal-Dementia-Information-Page" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Frontotemporal Dementia Information Page</a></div></li><li class="half_rhythm"><div><b>Rare Dementia Support </b></div><div>United Kingdom</div><div><b>Email:</b> contact@raredementiasupport.org</div><div><a href="http://www.raredementiasupport.org/ftd/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.raredementiasupport.org/ftd</a></div></li><li class="half_rhythm"><div><b>FTD Disorders Registry</b></div><div><a href="https://ftdregistry.org/?utm_campaign=website-launch&#x00026;utm_medium=referral&#x00026;utm_source=theaftd.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">FTD Disorders Registry</a></div></li></ul></div><div id="ftd-chmp2b.Molecular_Genetics"><h2 id="_ftd-chmp2b_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="ftd-chmp2b.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Frontotemporal Dementia, Chromosome 3-Linked: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1199/table/ftd-chmp2b.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ftd-chmp2b.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_ftd-chmp2b.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_ftd-chmp2b.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_ftd-chmp2b.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_ftd-chmp2b.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_ftd-chmp2b.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_ftd-chmp2b.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_ftd-chmp2b.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/25978" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>CHMP2B</i></a></td><td headers="hd_b_ftd-chmp2b.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=25978" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">3p11<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_b_ftd-chmp2b.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q9UQN3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Charged multivesicular body protein 2b</a></td><td headers="hd_b_ftd-chmp2b.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://alsod.iop.kcl.ac.uk/Als/Overview/gene.aspx?gene_id=CHMP2B" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">alsod/CHMP2B genetic mutations</a><br /><a href="http://reseq.biosciencedbc.jp/resequence/GeneDetail.do?targetId=1&#x00026;geneId=EG25978" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ALS mutation database (CHMP2B)</a><br /><a href="http://www.molgen.ua.ac.be/ADMutations/default.cfm?MT=1&#x00026;ML=0&#x00026;Page=ADMDB" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Alzheimer Disease &#x00026; Frontotemporal Dementia Mutation Database (CHMP2B)</a><br /><a href="http://databases.lovd.nl/shared/genes/CHMP2B" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CHMP2B database</a></td><td headers="hd_b_ftd-chmp2b.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=CHMP2B" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CHMP2B</a></td><td headers="hd_b_ftd-chmp2b.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=CHMP2B[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CHMP2B</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="ftd-chmp2b.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="ftd-chmp2b.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Frontotemporal Dementia, Chromosome 3-Linked (<a href="/omim/600795,609512" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1199/table/ftd-chmp2b.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ftd-chmp2b.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/600795" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">600795</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">FRONTOTEMPORAL DEMENTIA, CHROMOSOME 3-LINKED; FTD3</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/609512" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">609512</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">CHMP FAMILY, MEMBER 2B; CHMP2B</td></tr></tbody></table></div></div><p><b>Gene structure.</b>
<i>CHMP2B</i> comprises six exons. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1199/#ftd-chmp2b.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Benign variants.</b> While no normal variants are known, there are <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants of unknown clinical significance, some of which may in future be demonstrated to be benign.</p><p><b>Pathogenic variants.</b> The <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> c.532-1G&#x0003e;C is a <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variant leading to the formation of two aberrant transcripts that code for proteins lacking the C terminus of the protein [<a class="bk_pop" href="#ftd-chmp2b.REF.skibinski.2005.806">Skibinski et al 2005</a>] (<a class="figpopup" href="/books/NBK1199/table/ftd-chmp2b.T.selected_chmp2b_pathogenic/?report=objectonly" target="object" rid-figpopup="figftdchmp2bTselectedchmp2bpathogenic" rid-ob="figobftdchmp2bTselectedchmp2bpathogenic">Table 2</a>); c.493C&#x0003e;T, a <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> pathogenic nonsense variant also predicted to lead to a protein lacking the C terminus, was subsequently identified in a Belgian individual with <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> frontotemporal lobar degeneration (FTLD) [<a class="bk_pop" href="#ftd-chmp2b.REF.van_der_zee.2008.313">van der Zee et al 2008</a>].</p><div id="ftd-chmp2b.T.selected_chmp2b_pathogenic" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Selected <i>CHMP2B</i> Pathogenic Variants</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1199/table/ftd-chmp2b.T.selected_chmp2b_pathogenic/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ftd-chmp2b.T.selected_chmp2b_pathogenic_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_ftd-chmp2b.T.selected_chmp2b_pathogenic_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_ftd-chmp2b.T.selected_chmp2b_pathogenic_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_ftd-chmp2b.T.selected_chmp2b_pathogenic_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequence</th></tr></thead><tbody><tr><td headers="hd_h_ftd-chmp2b.T.selected_chmp2b_pathogenic_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.532-1G&#x0003e;C</td><td headers="hd_h_ftd-chmp2b.T.selected_chmp2b_pathogenic_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td><td headers="hd_h_ftd-chmp2b.T.selected_chmp2b_pathogenic_1_1_1_3" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/NM_014043.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_014043<wbr style="display:inline-block"></wbr>​.3</a></td></tr><tr><td headers="hd_h_ftd-chmp2b.T.selected_chmp2b_pathogenic_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.493C&#x0003e;T</td><td headers="hd_h_ftd-chmp2b.T.selected_chmp2b_pathogenic_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gln165Ter</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Variants of unknown clinical significance.</b> The following variants have been identified in a few cases; their clinical significance has yet to be demonstrated (<a class="figpopup" href="/books/NBK1199/table/ftd-chmp2b.T.selected_chmp2b_variants_of/?report=objectonly" target="object" rid-figpopup="figftdchmp2bTselectedchmp2bvariantsof" rid-ob="figobftdchmp2bTselectedchmp2bvariantsof">Table 3</a>).</p><div id="ftd-chmp2b.T.selected_chmp2b_variants_of" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Selected <i>CHMP2B</i> Variants of Unknown Clinical Significance</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1199/table/ftd-chmp2b.T.selected_chmp2b_variants_of/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ftd-chmp2b.T.selected_chmp2b_variants_of_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_ftd-chmp2b.T.selected_chmp2b_variants_of_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_ftd-chmp2b.T.selected_chmp2b_variants_of_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_ftd-chmp2b.T.selected_chmp2b_variants_of_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences&#x000a0;<sup>1</sup></th><th id="hd_h_ftd-chmp2b.T.selected_chmp2b_variants_of_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference</th></tr></thead><tbody><tr><td headers="hd_h_ftd-chmp2b.T.selected_chmp2b_variants_of_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.85A&#x0003e;G</td><td headers="hd_h_ftd-chmp2b.T.selected_chmp2b_variants_of_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ile29Val&#x000a0;<sup>2</sup></td><td headers="hd_h_ftd-chmp2b.T.selected_chmp2b_variants_of_1_1_1_3" rowspan="5" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/NM_014043" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_014043<wbr style="display:inline-block"></wbr>​.3</a><br /><a href="/protein/40254866" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_054762<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_h_ftd-chmp2b.T.selected_chmp2b_variants_of_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#ftd-chmp2b.REF.cannon.2006.83">Cannon et al [2006]</a><br /><a class="bk_pop" href="#ftd-chmp2b.REF.parkinson.2006.1074">Parkinson et al [2006]</a><br /><a class="bk_pop" href="#ftd-chmp2b.REF.rizzu.2006.944">Rizzu et al [2006]</a><br /><a class="bk_pop" href="#ftd-chmp2b.REF.cox.2010.e9872">Cox et al [2010]</a></td></tr><tr><td headers="hd_h_ftd-chmp2b.T.selected_chmp2b_variants_of_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.311C&#x0003e;A</td><td headers="hd_h_ftd-chmp2b.T.selected_chmp2b_variants_of_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Thr104Asn&#x000a0;<sup>3</sup></td><td headers="hd_h_ftd-chmp2b.T.selected_chmp2b_variants_of_1_1_1_4" colspan="1" rowspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#ftd-chmp2b.REF.cox.2010.e9872">Cox et al [2010]</a></td></tr><tr><td headers="hd_h_ftd-chmp2b.T.selected_chmp2b_variants_of_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.442G&#x0003e;T</td><td headers="hd_h_ftd-chmp2b.T.selected_chmp2b_variants_of_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asp148Tyr&#x000a0;<sup>4</sup></td><td headers="hd_h_ftd-chmp2b.T.selected_chmp2b_variants_of_1_1_1_4" colspan="1" rowspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#ftd-chmp2b.REF.skibinski.2005.806">Skibinski et al [2005]</a></td></tr><tr><td headers="hd_h_ftd-chmp2b.T.selected_chmp2b_variants_of_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">556C&#x0003e;T</td><td headers="hd_h_ftd-chmp2b.T.selected_chmp2b_variants_of_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg186Ter&#x000a0;<sup>5</sup></td><td headers="hd_h_ftd-chmp2b.T.selected_chmp2b_variants_of_1_1_1_4" colspan="1" rowspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#ftd-chmp2b.REF.momeni.2006b.129">Momeni et al [2006b]</a></td></tr><tr><td headers="hd_h_ftd-chmp2b.T.selected_chmp2b_variants_of_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">618A&#x0003e;C</td><td headers="hd_h_ftd-chmp2b.T.selected_chmp2b_variants_of_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gln206His&#x000a0;<sup>6</sup></td><td headers="hd_h_ftd-chmp2b.T.selected_chmp2b_variants_of_1_1_1_4" colspan="1" rowspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#ftd-chmp2b.REF.parkinson.2006.1074">Parkinson et al [2006]</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="ftd-chmp2b.TF.3.1"><p class="no_margin">Reference sequence (<a href="/Genbank/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www<wbr style="display:inline-block"></wbr>​.ncbi.nlm.nih.gov/Genbank</a>)</p></div></dd><dt>2. </dt><dd><div id="ftd-chmp2b.TF.3.2"><p class="no_margin">Cases identified: 2 frontotemporal dementia, 1 frontotemporal dementia-amyotrophic lateral sclerosis, 2 primary muscular atrophy, 1 control</p></div></dd><dt>3. </dt><dd><div id="ftd-chmp2b.TF.3.3"><p class="no_margin">Cases identified: 1 primary muscular atrophy</p></div></dd><dt>4. </dt><dd><div id="ftd-chmp2b.TF.3.4"><p class="no_margin">Cases identified: 1 frontotemporal dementia</p></div></dd><dt>5. </dt><dd><div id="ftd-chmp2b.TF.3.5"><p class="no_margin">Cases identified: 1 control</p></div></dd><dt>6. </dt><dd><div id="ftd-chmp2b.TF.3.6"><p class="no_margin">Cases identified: 1 primary muscular atrophy</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The CHMP2B protein appears to be part of the ESCRT-III complex, which is required for formation of the multivesicular body.</p><p>CHMP2B is an abbreviation of charged multivesicular body protein 2B (also known as chromatin modifying protein 2B). Human CHMP2B belongs to a set of class E Vps proteins that form three separate heteromeric protein complexes: ESCRT-I, ESCRT-II, and ESCRT-III. These protein complexes are transiently recruited from the cytoplasm to the endosomal membrane where they function sequentially in the sorting of the transmembrane proteins into the multivesicular bodies (MVB) pathway.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> C-terminally truncated mutated CHMP2B protein impairs trafficking in the MVB and autophagy pathways [<a class="bk_pop" href="#ftd-chmp2b.REF.filimonenko.2007.485">Filimonenko et al 2007</a>, <a class="bk_pop" href="#ftd-chmp2b.REF.lee.2007.1561">Lee et al 2007</a>, <a class="bk_pop" href="#ftd-chmp2b.REF.urwin.2010.2228">Urwin et al 2010</a>]. Expression of a C-terminally truncated mutated CHMP2B in transgenic mice recapitulates aspects of the neuropathology observed in the brains of individuals with FTD3 including p62- and ubiquitin-positive, TDP-43 and FUS-negative inclusions [<a class="bk_pop" href="#ftd-chmp2b.REF.ghazinoori.2012.819">Ghazi-Noori et al 2012</a>]. This suggests that the C-terminal truncation drives the neuropathologic changes observed in FTD3, but loss of function of CHMP2B could still contribute to other aspects on the disease <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</p></div><div id="ftd-chmp2b.References"><h2 id="_ftd-chmp2b_References_">References</h2><div id="ftd-chmp2b.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="ftd-chmp2b.REF.baker.2006.916">Baker M, Mackenzie IR, Pickering-Brown SM, Gass J, Rademakers R, Lindholm C, Snowden J, Adamson J, Sadovnick AD, Rollinson S, Cannon A, Dwosh E, Neary D, Melquist S, Richardson A, Dickson D, Berger Z, Eriksen J, Robinson T, Zehr C, Dickey CA, Crook R, McGowan E, Mann D, Boeve B, Feldman H, Hutton M. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. <span><span class="ref-journal">Nature. </span>2006;<span class="ref-vol">442</span>:916–9.</span> [<a href="/pubmed/16862116" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16862116</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ftd-chmp2b.REF.behrens.2007.1">Behrens MI, Mukherjee O, Tu PH, Liscic RM, Grinberg LT, Carter D, Paulsmeyer K, Taylor-Reinwald L, Gitcho M, Norton JB, Chakraverty S, Goate AM, Morris JC, Cairns NJ. Neuropathologic heterogeneity in HDDD1: a familial frontotemporal lobar degeneration with ubiquitin-positive inclusions and progranulin mutation. <span><span class="ref-journal">Alzheimer Dis Assoc Disord. </span>2007;<span class="ref-vol">21</span>:1–7.</span> [<a href="/pubmed/17334266" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17334266</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ftd-chmp2b.REF.bird.1999.741">Bird TD, Nochlin D, Poorkaj P, Cherrier M, Kaye J, Payami H, Peskind E, Lampe TH, Nemens E, Boyer PJ, Schellenberg GD. A clinical pathological comparison of three families with frontotemporal dementia and identical mutations in the tau gene (P301L). <span><span class="ref-journal">Brain. </span>1999;<span class="ref-vol">122</span>:741–56.</span> [<a href="/pubmed/10219785" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10219785</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ftd-chmp2b.REF.blair.2008.849">Blair IP, Vance C, Durnall JC, Williams KL, Thoeng A, Shaw CE, Nicholson GA. CHMP2B mutations are not a common cause of familial or sporadic amyotrophic lateral sclerosis. <span><span class="ref-journal">J Neurol Neurosurg Psychiatry. </span>2008;<span class="ref-vol">79</span>:849–50.</span> [<a href="/pubmed/18270236" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18270236</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ftd-chmp2b.REF.brown.1995.1625">Brown J, Ashworth A, Gydesen S, Sorensen A, Rossor M, Hardy J, Collinge J. Familial non-specific dementia maps to chromosome 3. <span><span class="ref-journal">Hum Mol Genet. </span>1995;<span class="ref-vol">4</span>:1625–8.</span> [<a href="/pubmed/8541850" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8541850</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ftd-chmp2b.REF.brown.2004.274">Brown J, Gydesen S, Johannsen P, Gade A, Skibinski G, Chakrabarti L, Brun A, Spillantini M, Yancopoulou D, Thusgaard T, Sorensen A, Fisher E, Collinge J. Frontotemporal dementia linked to chromosome 3. <span><span class="ref-journal">Dement Geriatr Cogn Disord. </span>2004;<span class="ref-vol">17</span>:274–6.</span> [<a href="/pubmed/15178935" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15178935</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ftd-chmp2b.REF.cairns.2007.5">Cairns NJ, Bigio EH, Mackenzie IR, Neumann M, Lee VM, Hatanpaa KJ, White CL 3rd, Schneider JA, Grinberg LT, Halliday G, Duyckaerts C, Lowe JS, Holm IE, Tolnay M, Okamoto K, Yokoo H, Murayama S, Woulfe J, Munoz DG, Dickson DW, Ince PG, Trojanowski JQ, Mann DM. Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration. <span><span class="ref-journal">Acta Neuropathol (Berl). </span>2007;<span class="ref-vol">114</span>:5–22.</span> [<a href="/pmc/articles/PMC2827877/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2827877</span></a>] [<a href="/pubmed/17579875" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17579875</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ftd-chmp2b.REF.cannon.2006.83">Cannon A, Baker M, Boeve B, Josephs K, Knopman D, Petersen R, Parisi J, Dickison D, Adamson J, Snowden J, Neary D, Mann D, Hutton M, Pickering-Brown SM. CHMP2B mutations are not a common cause of frontotemporal lobar degeneration. <span><span class="ref-journal">Neurosci Lett. </span>2006;<span class="ref-vol">398</span>:83–4.</span> [<a href="/pubmed/16431024" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16431024</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ftd-chmp2b.REF.cox.2010.e9872">Cox LE, Ferraiuolo L, Goodall EF, Heath PR, Higginbottom A, Mortiboys H, Hollinger HC, Hartley JA, Brockington A, Burness CE, Morrison KE, Wharton SB, Grierson AJ, Ince PG, Kirby J, Shaw PJ. Mutations in CHMP2B in lower motor neuron predominant amyotrophic lateral sclerosis (ALS). <span><span class="ref-journal">PLoS One. </span>2010;<span class="ref-vol">5</span>:e9872.</span> [<a href="/pmc/articles/PMC2844426/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2844426</span></a>] [<a href="/pubmed/20352044" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20352044</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ftd-chmp2b.REF.dejesushernandez.2011.245">DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, Nicholson AM, Finch NA, Flynn H, Adamson J, Kouri N, Wojtas A, Sengdy P, Hsiung GY, Karydas A, Seeley WW, Josephs KA, Coppola G, Geschwind DH, Wszolek ZK, Feldman H, Knopman DS, Petersen RC, Miller BL, Dickson DW, Boylan KB, Graff-Radford NR, Rademakers R. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. <span><span class="ref-journal">Neuron. </span>2011;<span class="ref-vol">72</span>:245–56.</span> [<a href="/pmc/articles/PMC3202986/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3202986</span></a>] [<a href="/pubmed/21944778" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21944778</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ftd-chmp2b.REF.filimonenko.2007.485">Filimonenko M, Stuffers S, Raiborg C, Yamamoto A, Malerod L, Fisher EM, Isaacs A, Brech A, Stenmark H, Simonsen A. Functional multivesicular bodies are required for autophagic clearance of protein aggregates associated with neurodegenerative disease. <span><span class="ref-journal">J Cell Biol. </span>2007;<span class="ref-vol">179</span>:485–500.</span> [<a href="/pmc/articles/PMC2064794/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2064794</span></a>] [<a href="/pubmed/17984323" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17984323</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ftd-chmp2b.REF.foster.1997.706">Foster NL, Wilhelmsen K, Sima AA, Jones MZ, D'Amato CJ, Gilman S. Frontotemporal dementia and parkinsonism linked to chromosome 17: a consensus conference. Conference Participants. <span><span class="ref-journal">Ann Neurol. </span>1997;<span class="ref-vol">41</span>:706–15.</span> [<a href="/pubmed/9189031" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9189031</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ftd-chmp2b.REF.ghanim.2010.2032">Ghanim M, Guillot-Noel L, Pasquier F, Jornea L, Deramecourt V, Dubois B, Le Ber I, Brice A., French Research Network on FTD and FTD/MND.  CHMP2B mutations are rare in French families with frontotemporal lobar degeneration. <span><span class="ref-journal">J Neurol. </span>2010;<span class="ref-vol">257</span>:2032–6.</span> [<a href="/pubmed/20625756" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20625756</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ftd-chmp2b.REF.ghazinoori.2012.819">Ghazi-Noori S, Froud KE, Mizielinska S, Powell C, Smidak M. Fernandez dM, O'Malley C, Farmer M, Parkinson N, Fisher EM, Asante EA, Brandner S, Collinge J, Isaacs AM. Progressive neuronal inclusion formation and axonal degeneration in CHMP2B mutant transgenic mice. <span><span class="ref-journal">Brain. </span>2012;<span class="ref-vol">135</span>:819–32.</span> [<a href="/pubmed/22366797" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22366797</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ftd-chmp2b.REF.gydesen.2002.1585">Gydesen S, Brown JM, Brun A, Chakrabarti L, Gade A, Johannsen P, Rossor M, Thusgaard T, Grove A, Yancopoulou D, Spillantini MG, Fisher EM, Collinge J, Sorensen SA. Chromosome 3 linked frontotemporal dementia (FTD-3). <span><span class="ref-journal">Neurology. </span>2002;<span class="ref-vol">59</span>:1585–94.</span> [<a href="/pubmed/12451202" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12451202</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ftd-chmp2b.REF.gydesen.1987.276">Gydesen S, Hagen S, Klinken L, Abelskov J, Sorensen SA. Neuropsychiatric studies in a family with presenile dementia different from Alzheimer and Pick disease. <span><span class="ref-journal">Acta Psychiatr Scand. </span>1987;<span class="ref-vol">76</span>:276–84.</span> [<a href="/pubmed/3673655" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 3673655</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ftd-chmp2b.REF.holm.2007.884">Holm IE, Englund E, Mackenzie IRA, Johannsen P, Isaacs AM. A reassessment of the neuropathology of frontotemporal dementia linked to chromosome 3 (FTD-3). <span><span class="ref-journal">J Neuropathol Exp Neurol. </span>2007;<span class="ref-vol">66</span>:884–91.</span> [<a href="/pubmed/17917582" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17917582</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ftd-chmp2b.REF.holm.2009.719">Holm IE, Isaacs AM, Mackenzie IRA. Absence of FUS-immunoreactive pathology in frontotemporal dementia linked to chromosome 3 (FTD-3) caused by mutation in the CHMP2B gene. <span><span class="ref-journal">Acta Neuropathol. </span>2009;<span class="ref-vol">118</span>:719–20.</span> [<a href="/pubmed/19844732" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19844732</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ftd-chmp2b.REF.isaacs.2011.246">Isaacs AM, Johannsen P, Holm I, Nielsen JE. FReJA consortium. Frontotemporal dementia caused by CHMP2B mutations. <span><span class="ref-journal">Curr Alzheimer Res. </span>2011;<span class="ref-vol">8</span>:246–51.</span> [<a href="/pmc/articles/PMC3182073/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3182073</span></a>] [<a href="/pubmed/21222599" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21222599</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ftd-chmp2b.REF.josephs.2007.142">Josephs KA, Ahmed Z, Katsuse O, Parisi JF, Boeve BF, Knopman DS, Petersen RC, Davies P, Duara R, Graff-Radford NR, Uitti RJ, Rademakers R, Adamson J, Baker M, Hutton ML, Dickson DW. Neuropathologic features of frontotemporal lobar degeneration with ubiquitin-positive inclusions with progranulin gene (PGRN) mutations. <span><span class="ref-journal">J Neuropathol Exp Neurol. </span>2007;<span class="ref-vol">66</span>:142–51.</span> [<a href="/pubmed/17278999" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17278999</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ftd-chmp2b.REF.lee.2007.1561">Lee JA, Beigneux A, Ahmad ST, Young SG, Gao FB. ESCRT-III dysfunction causes autophagosome accumulation and neurodegeneration. <span><span class="ref-journal">Curr Biol. </span>2007;<span class="ref-vol">17</span>:1561–7.</span> [<a href="/pubmed/17683935" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17683935</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ftd-chmp2b.REF.lindquist.2008.667">Lindquist SG, Br&#x000e6;ndgaard H, Svenstrup K, Isaacs AM, Nielsen JE. on behalf of the FReJA Consortium. Frontotemporal dementia linked to chromosome 3 (FTD-3) &#x02013; current concepts and the detection of a previously unknown branch of the Danish FTD-3 family. <span><span class="ref-journal">Eur J Neurol. </span>2008;<span class="ref-vol">15</span>:667–70.</span> [<a href="/pubmed/18484988" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18484988</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ftd-chmp2b.REF.mackenzie.2010.1">Mackenzie IR, Neumann M, Bigio EH, Cairns NJ, Alafuzoff I, Kril J, Kovacs GG, Ghetti B, Halliday G, Holm IE, Ince PG, Kamphorst W, Revesz T, Rozemuller AJ, Kumar-Singh S, Akiyama H, Baborie A, Spina S, Dickson DW, Trojanowski JQ, Mann DM. Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update. <span><span class="ref-journal">Acta Neuropathol. </span>2010;<span class="ref-vol">119</span>:1–4.</span> [<a href="/pmc/articles/PMC2799633/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2799633</span></a>] [<a href="/pubmed/19924424" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19924424</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ftd-chmp2b.REF.masellis.2006.3115">Masellis M, Momeni P, Meschino W, Heffner R Jr, Elder J, Sato C, Liang Y, St George-Hyslop P, Hardy J, Bilbao J, Black S, Rogaeva E. Novel splicing mutation in the progranulin gene causing familial corticobasal syndrome. <span><span class="ref-journal">Brain. </span>2006;<span class="ref-vol">129</span>:3115–23.</span> [<a href="/pubmed/17030534" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17030534</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ftd-chmp2b.REF.mesulam.2007.43">Mesulam M, Johnson N, Krefft TA, Gass JM, Cannon AD, Adamson JL, Bigio EH, Weintraub S, Dickson DW, Hutton ML, Graff-Radford NR. Progranulin mutations in primary progressive aphasia: the PPA1 and PPA3 families. <span><span class="ref-journal">Arch Neurol. </span>2007;<span class="ref-vol">64</span>:43–7.</span> [<a href="/pubmed/17210807" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17210807</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ftd-chmp2b.REF.momeni.2006a.77">Momeni P, Bell J, Duckworth J, Hutton M, Mann D, Brown SP, Hardy J. Sequence analysis of all identified open reading frames on the frontal temporal dementia haplotype on chromosome 3 fails to identify unique coding variants except in CHMP2B. <span><span class="ref-journal">Neurosci Lett. </span>2006a;<span class="ref-vol">410</span>:77–9.</span> [<a href="/pubmed/17095158" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17095158</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ftd-chmp2b.REF.momeni.2006b.129">Momeni P, Rogaeva E, Van Deerlin V, Yuan W, Grafman J, Tierney M, Huey E, Bell J, Morris CM, Kalaria RN, van Rensburg SJ, Niehaus D, Potocnik F, Kawarai T, Salehi-Rad S, Sato C, St George-Hyslop P, Hardy J. Genetic variability in CHMP2B and frontotemporal dementia. <span><span class="ref-journal">Neurodegener Dis. </span>2006b;<span class="ref-vol">3</span>:129–33.</span> [<a href="/pubmed/16954699" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16954699</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ftd-chmp2b.REF.mukherjee.2006.314">Mukherjee O, Pastor P, Cairns NJ, Chakraverty S, Kauwe JS, Shears S, Behrens MI, Budde J, Hinrichs AL, Norton J, Levitch D, Taylor-Reinwald L, Gitcho M, Tu PH, Tenenholz Grinberg L, Liscic RM, Armendariz J, Morris JC, Goate AM. HDDD2 is a familial frontotemporal lobar degeneration with ubiquitin-positive, tau-negative inclusions caused by a missense mutation in the signal peptide of progranulin. <span><span class="ref-journal">Ann Neurol. </span>2006;<span class="ref-vol">60</span>:314–22.</span> [<a href="/pmc/articles/PMC2803024/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2803024</span></a>] [<a href="/pubmed/16983685" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16983685</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ftd-chmp2b.REF.nielsen.2012.521">Nielsen TT, Mizielinska S, Hasholt L, Isaacs AM, Nielsen JE. the FReJA Consortium. Reversal of pathology in CHMP2B-mediated frontotemporal dementia patient cells using RNA interference. <span><span class="ref-journal">J Gene Med. </span>2012;<span class="ref-vol">14</span>:521–9.</span> [<a href="/pubmed/22786763" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22786763</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ftd-chmp2b.REF.parkinson.2006.1074">Parkinson N, Ince PG, Smith MO, Highley R, Skibinski G, Andersen PM, Morrison KE, Pall HS, Hardiman O, Collinge J, Shaw PJ, Fisher EM. ALS phenotypes with mutations in CHMP2B (charged multivesicular body protein 2B). <span><span class="ref-journal">Neurology. </span>2006;<span class="ref-vol">67</span>:1074–7.</span> [<a href="/pubmed/16807408" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16807408</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ftd-chmp2b.REF.renton.2011.257">Renton AE, Majounie E, Waite A, Sim&#x000f3;n-S&#x000e1;nchez J, Rollinson S, Gibbs JR, Schymick JC, Laaksovirta H, van Swieten JC, Myllykangas L, Kalimo H, Paetau A, Abramzon Y, Remes AM, Kaganovich A, Scholz SW, Duckworth J, Ding J, Harmer DW, Hernandez DG, Johnson JO, Mok K, Ryten M, Trabzuni D, Guerreiro RJ, Orrell RW, Neal J, Murray A, Pearson J, Jansen IE, Sondervan D, Seelaar H, Blake D, Young K, Halliwell N, Callister JB, Toulson G, Richardson A, Gerhard A, Snowden J, Mann D, Neary D, Nalls MA, Peuralinna T, Jansson L, Isoviita VM, Kaivorinne AL, H&#x000f6;ltt&#x000e4;-Vuori M, Ikonen E, Sulkava R, Benatar M, Wuu J, Chi&#x000f2; A, Restagno G, Borghero G, Sabatelli M., ITALSGEN Consortium.  Heckerman D, Rogaeva E, Zinman L, Rothstein JD, Sendtner M, Drepper C, Eichler EE, Alkan C, Abdullaev Z, Pack SD, Dutra A, Pak E, Hardy J, Singleton A, Williams NM, Heutink P, Pickering-Brown S, Morris HR, Tienari PJ, Traynor BJ. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. <span><span class="ref-journal">Neuron. </span>2011;<span class="ref-vol">72</span>:257–68.</span> [<a href="/pmc/articles/PMC3200438/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3200438</span></a>] [<a href="/pubmed/21944779" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21944779</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ftd-chmp2b.REF.rizzu.2006.944">Rizzu P, van Mil SE, Anar B, Rosso SM, Kaat LD, Heutink P, van Swieten JC. CHMP2B mutations are not a cause of dementia in Dutch patients with familial and sporadic frontotemporal dementia. <span><span class="ref-journal">Am J Med Genet B Neuropsychiatr Genet. </span>2006;<span class="ref-vol">141B</span>:944–6.</span> [<a href="/pubmed/16941655" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16941655</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ftd-chmp2b.REF.skibinski.2005.806">Skibinski G, Parkinson NJ, Brown JM, Chakrabarti L, Lloyd SL, Hummerich H, Nielsen JE, Hodges JR, Spillantini MG, Thusgaard T, Brandner S, Brun A, Rossor MN, Gade A, Johannsen P, Sorensen SA, Gydesen S, Fisher EM, Collinge J. Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia. <span><span class="ref-journal">Nat Genet. </span>2005;<span class="ref-vol">37</span>:806–8.</span> [<a href="/pubmed/16041373" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16041373</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ftd-chmp2b.REF.spina.2007.820">Spina S, Murrell JR, Huey ED, Wassermann EM, Pietrini P, Baraibar MA, Barbeito AG, Troncoso JC, Vidal R, Ghetti B, Grafman J. Clinicopathologic features of frontotemporal dementia with progranulin sequence variation. <span><span class="ref-journal">Neurology. </span>2007;<span class="ref-vol">68</span>:820–7.</span> [<a href="/pubmed/17202431" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17202431</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ftd-chmp2b.REF.urwin.2010.2228">Urwin H, Authier A, Nielsen JE, Metcalf D, Powell C, Froud K, Malcolm DS, Holm I, Johannsen P, Brown J, Fisher EM. van der ZJ, Bruyland M, Van Broeckhoven C, Collinge J, Brandner S, Futter C, Isaacs AM. Disruption of endocytic trafficking in frontotemporal dementia with CHMP2B mutations. <span><span class="ref-journal">Hum Mol Genet. </span>2010;<span class="ref-vol">19</span>:2228–38.</span> [<a href="/pmc/articles/PMC2865375/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2865375</span></a>] [<a href="/pubmed/20223751" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20223751</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ftd-chmp2b.REF.van_der_zee.2008.313">van der Zee J, Urwin H, Engelborghs S, Bruyland M, Vandenberghe R, Dermaut B, De Pooter T, Peeters K, Santens P, De Deyn PP, Fisher EM, Collinge J, Isaacs AM, Van Broeckhoven C. CHMP2B C-truncating mutations in frontotemporal lobar degeneration are associated with an aberrant endosomal phenotype in vitro. <span><span class="ref-journal">Hum Mol Genet. </span>2008;<span class="ref-vol">17</span>:313–22.</span> [<a href="/pubmed/17956895" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17956895</span></a>]</div></li></ul></div></div><div id="ftd-chmp2b.Chapter_Notes"><h2 id="_ftd-chmp2b_Chapter_Notes_">Chapter Notes</h2><div id="ftd-chmp2b.Acknowledgments"><h3>Acknowledgments</h3><p>The Danish family is studied by the FReJA (Frontotemporal dementia Research in Jutland Association) Consortium that includes the authors and the following:</p><p>Anders Gade, PhD <br />Institute of Psychology <br />Copenhagen University<br />Copenhagen, Denmark</p><p>Jette Stokholm, Neuropsychologist<br />Memory Disorders Research Group<br />Department of Neurology, Rigshospitalet<br />Copenhagen University Hospital<br />Copenhagen, Denmark</p><p>Susanne Gydesen, MD <br />Psychiatric Center Ballerup<br />Copenhagen University Hospital<br />Ballerup, Denmark</p><p>Troels Tolstrup Nielsen, PhD<br />Neurogenetics Clinic<br />Memory Disorders Research Group<br />Department of Neurology, Rigshospitalet<br />Copenhagen University Hospital<br />Copenhagen, Denmark</p><p>Tove Thusgaard, RN <br />Health and Social Services <i>Distrikt Parkvej</i>
<br />Holstebro Municipality<br />Holstebro, Denmark</p><p>Elisabet Englund, MD, PhD <br />Department of Pathology <br />University Hospital of Lund<br />Lund, Sweden</p><p>John Collinge, MD <br />MRC Prion Unit <br />Department of Neurodegenerative Diseases <br />Institute of Neurology <br />University College London<br />London, UK</p><p>Martin Rossor, MD and Elizabeth MC Fisher, PhD <br />Department of Neurodegenerative Diseases <br />Institute of Neurology <br />University College London<br />London, UK</p></div><div id="ftd-chmp2b.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>4 October 2012 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>23 August 2007 (me) Review posted live</div></li><li class="half_rhythm"><div>11 July 2007 (ih) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1199</span><span class="label">PMID: <a href="/pubmed/20301378" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301378</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/friedreich/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/fructose1-6-def/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1199&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1199/?report=reader">PubReader</a></li><li><a href="/books/NBK1199/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1199" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1199" style="display:none" title="Cite this Page"><div class="bk_tt">Holm IE, Nielsen JE, Brown JM, et al. Frontotemporal Dementia, Chromosome 3-Linked. 2007 Aug 23 [Updated 2012 Oct 4]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1199/pdf/Bookshelf_NBK1199.pdf">PDF version of this page</a> (442K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#ftd-chmp2b.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#ftd-chmp2b.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#ftd-chmp2b.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#ftd-chmp2b.Genetically_Related_Allelic_D" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#ftd-chmp2b.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#ftd-chmp2b.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#ftd-chmp2b.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#ftd-chmp2b.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#ftd-chmp2b.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#ftd-chmp2b.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#ftd-chmp2b.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=25978[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">CHMP2B</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Variations in ClinVar</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=NBK1199+AND+genereviews[submitter]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Variations from this GeneReview in ClinVar</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1484702" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1484702" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1484702" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1484702" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301678" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">MAPT</i>-Related Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">MAPT</i>-Related Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">van Swieten JC, Rosso SM, Heutink P. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301545" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">GRN</i>-Related Frontotemporal Dementia</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">GRN</i>-Related Frontotemporal Dementia<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Hsiung GYR, Feldman HH. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/25577942" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">C9orf72</i>-Related Amyotrophic Lateral Sclerosis and Frontotemporal Dementia</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">C9orf72</i>-Related Amyotrophic Lateral Sclerosis and Frontotemporal Dementia<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Cruts M, Engelborghs S, van der Zee J, Van Broeckhoven C. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/27329763" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedarticles&amp;logdbfrom=pubmed">A transgenic mouse expressing CHMP2Bintron5 mutant in neurons develops histological and behavioural features of amyotrophic lateral sclerosis and frontotemporal dementia.</a><span class="source">[Hum Mol Genet. 2016]</span><div class="brieflinkpop offscreen_noflow">A transgenic mouse expressing CHMP2Bintron5 mutant in neurons develops histological and behavioural features of amyotrophic lateral sclerosis and frontotemporal dementia.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Vernay A, Therreau L, Blot B, Risson V, Dirrig-Grosch S, Waegaert R, Lequeu T, Sellal F, Schaeffer L, Sadoul R, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Hum Mol Genet. 2016 Aug 1; 25(15):3341-3360. Epub 2016 Jun 21.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/17917582" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedarticles&amp;logdbfrom=pubmed">A reassessment of the neuropathology of frontotemporal dementia linked to chromosome 3.</a><span class="source">[J Neuropathol Exp Neurol. 2007]</span><div class="brieflinkpop offscreen_noflow">A reassessment of the neuropathology of frontotemporal dementia linked to chromosome 3.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Holm IE, Englund E, Mackenzie IR, Johannsen P, Isaacs AM. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">J Neuropathol Exp Neurol. 2007 Oct; 66(10):884-91. </em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301378" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301378" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5dfc91afdde08911697bbf56">Frontotemporal Dementia, Chromosome 3-Linked - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Frontotemporal Dementia, Chromosome 3-Linked - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-20T04:17:35-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal105&amp;ncbi_phid=CE8C7D22DFC876510000000005020254&amp;ncbi_session=CE8C7D22DFC91AF1_1282SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1199%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1199&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1199/&amp;ncbi_pagename=Frontotemporal Dementia, Chromosome 3-Linked - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8C7D22DFC91AF1_1282SID /projects/books/PBooks@5.22 portal105 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>